Spotlighting improved operational strategies to encourage improved transparency between trial sponsors and vendor partners
Outsourcing in Clinical Trials Nordics (OCT Nordics) is the leading conference in the Nordic region focusing on encouraging greater transparency between trial sponsors and vendors; alongside clinical operation excellence. OCT Nordics is part of our internationally renowned portfolio of clinical conferences, with this conference being tailored specifically for Clinical Operations/Development/Research, Medical Affairs pharma, biotech and medical device representatives in the Nordics region alongside international vendors.
With a dynamic programme written for the industry, by the industry, our 4th annual OCT Nordics event promises to be an engaging and memorable conference. Optimising clinical processes within clinical trials to support sponsor/vendor relationships, effective patient recruitment, and achieve trial success is central to this year’s conference.
Over the past 30 years, clinical research within the Nordic region has been on the wane. Henry Kerali explores a brief overview of recent clinical research within the Nordic region.
With an interactive and extensively researched agenda, featuring both biopharma and medical device streams, the 2016 event will welcome industry experts from across the Nordic region.
Guaranteeing the correct functioning of the clinical trial is a top priority in the pharmaceutical world. Home to some of the world’s most innovative pharma and biotech companies, the Nordic region is no exception to this challenge.
Henry Kerali examines the challenges and potential opportunites as a result of the European Union (EU) changes to be implemented by October 2018. View the full article on the ClinicalTrialsArena website here.
The 2016 agenda has been produced by industry experts to ensure the most relevant and timely topics are covered in-depth.
The new Clinical Trials Regulation EU No. 536/2014 is scheduled to come into play very soon. This regulation will ensure that clinical trial policies are standardised across the EU, guaranteeing the highest standards of patient safety.